Estimaciones de analistas de Wall Street para SANUWAVE Health Inc. (SNWV): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 2 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 2 |
| Calificación media (1-5) | 1.00 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-06 | $0.01 | ||
| 2026-08-06 | $-0.08 | $-0.03 | -166.7% |
| 2026-05-12 | $-0.17 | $-0.14 | -21.4% |
| 2026-03-26 | $0.03 | $0.17 | -82.4% |
| 2025-11-07 | $0.46 | $0.32 | +43.8% |
| 2025-08-08 | $0.01 | $-0.09 | +111.1% |
| 2025-05-09 | $-0.66 | ||
| 2025-03-20 | $-1.21 |
Ratios de valoración
| Ratio P/E | 2.47 |
| Precio / Valor contable | 12.75 |
| EV / EBITDA | 2.42 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.4M | $738527 | $1.9M | $1.0M | $4.1M | $13.0M | $16.7M | $20.4M | $32.6M | $44.1M |
| Coste de Ventas | $565129 | $241970 | $693664 | $538923 | $1.2M | $5.0M | $4.3M | $6.0M | $8.1M | $10.1M |
| Beneficio Bruto | $810934 | $496557 | $1.2M | $489807 | $2.9M | $8.0M | $12.4M | $14.4M | $24.6M | $34.0M |
| I+D | $1.1M | $1.3M | $1.7M | $1.2M | $1.2M | $1.1M | $567000 | $579000 | $673000 | $1.4M |
| Generales y Administrativos | $2.7M | $3.0M | $7.3M | $8.0M | $18.9M | $20.3M | $20.0M | $13.6M | $17.7M | $26.8M |
| Gastos Operativos | $4.1M | $4.3M | $8.3M | $9.3M | $28.1M | $22.2M | $21.4M | $14.9M | $19.1M | $29.0M |
| Beneficio Operativo | -$3.3M | -$3.8M | -$7.2M | -$8.8M | -$25.2M | -$14.1M | -$9.0M | -$540000 | $5.4M | $4.9M |
| EBITDA | -$3.0M | -$4.4M | -$7.1M | -$8.5M | -$27.4M | -$18.9M | $4.8M | -$9.2M | -$16.6M | $19.4M |
| Gastos por Intereses | $854980 | $1.1M | $4.5M | $1.8M | $2.5M | $7.1M | $14.1M | $15.6M | $13.6M | $6.2M |
| Beneficio Antes de Impuestos | -$6.4M | -$5.5M | -$11.6M | -$10.4M | -$30.9M | -$27.2M | -$10.3M | -$25.8M | -$31.3M | $11.9M |
| Impuestos | $3.1M | 0 | $45012 | 0 | 0 | $28000 | $2000 | $4000 | $27000 | $86000 |
| Beneficio Neto | -$6.4M | -$5.5M | -$11.6M | -$10.4M | -$30.9M | -$27.3M | -$10.3M | -$25.8M | -$31.4M | $11.8M |
| BPA | $-22.50 | $-15.00 | $-29.17 | $-19.26 | $-30.68 | $-19.72 | $-7.02 | $-12.19 | $-7.03 | $1.38 |
| BPA Diluido | $-22.50 | $-15.00 | $-29.17 | $-19.26 | $-30.68 | $-19.72 | $-7.02 | $-12.19 | $-7.03 | $0.41 |
| Acciones en Circulación (Diluidas) | $286986 | $370236 | $398767 | $541442 | $1.0M | $1.4M | $1.5M | $2.1M | $4.5M | $9.1M |
Precio
| Precio | $4.30 |
| Capitalización | $37M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: FHTX · HSDT · IMRX · INGN · MASS · NNOX · OM
Explorar sector: Healthcare · Medical - Devices
Más secciones de SNWV: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones